Sherbrooke Park Advisers’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
SCM
QF
DCM
GECH
Sherbrooke Park Advisers's ATEX Position: Q4 2024 in Review
Sherbrooke Park Advisers sold out of Anterix (ATEX) in Q4 2024, closing a stake of 5,941 shares — an estimated $224K sold.
Sherbrooke Park Advisers first reported a position in ATEX in Q1 2024 and held it in 2 quarters. The position peaked at $385K in Q1 2024. 115 funds tracked by Wall St. Rank hold ATEX as of Q4 2024.
- Sherbrooke Park Advisers reported no remaining Anterix position as of Q4 2024 after selling out during the quarter.
- Sherbrooke Park Advisers sold 5,941 Anterix shares in Q4 2024, an estimated $224K.
- Sherbrooke Park Advisers first reported a position in Anterix in Q1 2024 and held it in 2 quarters.
- Sherbrooke Park Advisers's Anterix position peaked at $385K in Q1 2024.
- 115 funds tracked by Wall St. Rank held Anterix as of Q4 2024.
Based on Sherbrooke Park Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.